Jiaodong Online, October 7 (Reporter Wang Xiangrong, Photography Li Gang, Correspondent Cai Jiangtao) As the first scientific research workstation in Yantai City that can independently recruit and train postdoctoral personnel, Yantai Rongchang Pharmaceutical Co., Ltd. postdoctoral research workstation Since its establishment in 2013, 8 postdoctoral personnel have completed scientific research tasks on schedule, and at present, there are 18 people in the station, and 4 people plan to enter the station. On the platform of Rongchang Bio's postdoctoral research workstation, more and more top talents have been gathered to drive the strong engine of Yantai's biopharmaceutical industry.
Zhao Chenggang, who entered the station in June 2022, is engaged in preclinical research of molecular targeted drugs, and is currently engaged in research in the fields of antibody drug conjugate combined immunotherapy, undertaking the construction of a non-clinical research platform for Rongchang Bio's autoimmune diseases, and responsible for the daily work of the translational scientific research laboratory of the non-clinical research department. He was selected as the 2022 Shandong Postdoctoral Innovation Talent Support Program and presided over the 2023 Shandong Postdoctoral Innovation Project (first class funding). He has published nearly 20 SCI papers in famous journals such as Neuro-Oncology, J Exp Clin Cancer Res, Theranostics, and Oncogenesis.
It is his interest to observe, record, and experiment back and forth in microbial culture rooms, cell culture rooms, molecular laboratories and other places every day, and find breakthroughs in data. "I work in the non-clinical research department, responsible for the evaluation and screening of large molecule drugs. To put it simply, my work is mainly to design the research protocol of the candidate molecular drugs provided by the upstream department and analyze the results, and my first job in the department is to study the mechanism of action of antibody drug conjugates and immunotherapy combinations. "After a period of hard work, with the efforts of our departmental team, I discovered a new mechanism of ADC drug combination therapy, which helps us screen more patients suitable for such methods, and enable those patients who are resistant to drugs to provide new treatments." With this research result, I personally won two postdoctoral talent projects in Shandong Province, relying on the funding, we can conduct more in-depth and specific research in the later stage. ”
Li Mingyang, who entered the station a month earlier than Zhao Cheng, went to school in the coastal city of Dalian, and when choosing a workstation, he also chose Yantai, which is also a coastal city, to join the Rongchang Biodoctoral Research Station, which is very strong in the field of biomedicine. "Before entering, the supervisor formulated the work direction and work content during the postdoctoral period according to the personal preliminary work basis and the scientific research needs of the company and the department. During the station, the easy-going atmosphere and professional environment also made me quickly adapt to the scientific research life at the station. I have benefited a lot from the professionalism of department leaders and colleagues, and the mature experimental platform has also provided a guarantee for the smooth development of scientific research. Speaking of the environment of the workstation, Li Mingyang spoke highly of it. Especially for matters such as entry station, thesis opening, mid-term, fund application, etc., the postdoctoral workstation can organize and issue notices in a timely manner, and can give detailed guidance. In the preparation of various materials, the leading colleagues of the workstation also provided professional guidance and support. Through professional and careful work management and life care, it effectively protects everyone's work and life during the station, so that he has no worries at all. At the same time, we will develop some updated methods in the cross-professional collision, and apply them, which will be unexpectedly inspired.
At present, Li Mingyang has bought a house in Yantai and settled down, enjoying Yantai's talent subsidy policy, and received a one-time subsidy of 296,000 yuan, "After entering, the leading colleagues of the workstation immediately introduced in detail the talent policies that postdoctoral fellows can enjoy, and the company and the workstation also actively provide assistance in various talent policy applications, and apply for various subsidies and benefits for everyone in a timely manner." With the help of the company and workstations, it has successfully applied for living subsidies and house purchase subsidies, and can also enjoy preferential policies such as talent identification, children's education and professional title evaluation. These talent policies have effectively mobilized everyone's enthusiasm. ”
Huang Tianwei, who has just been in the station for more than a month, is from Hubei and initially knew that Rongchang was still through Tai. Before studying in China, he saw that the development prospects of the domestic biomedical industry were good, especially the leading role of Remegen Biotech in the field of innovative drugs, and recognized the company's innovation and scientific research capabilities, so he chose the Rongchang Bio postdoctoral research workstation. "After one month of training, I found that the R&D atmosphere in the station is very good, and everyone exchanges R&D experience with each other, which will be of great help to future work."
Broad view and about taking, thick and thin. Qu Wenbo, director of the Rongchang Biotech Postdoctoral Research Station, introduced that the workstation mainly focuses on the front-end research of new biological drugs and related projects, improves the scientific and technological innovation ability of enterprises, solves key problems in scientific research and production, so as to enhance the technological innovation ability of enterprise development, and drives and cultivates a group of young and middle-aged discipline leaders and technical backbones to provide technical support for the company to achieve the launch and industrialization of new drugs. At present, the workstation scientific research projects have achieved remarkable results, and have won 1 first-class funding from the China Postdoctoral Science Foundation, 3 second-class grants from the China Postdoctoral Science Foundation, and 2 third-class grants from the Shandong Province Postdoctoral Innovation Project Special Fund, while the whole station has presided over and participated in more than 20 scientific research projects at other national, provincial and municipal levels, published papers and applied for nearly 20 patents.
The launch of new drugs is inseparable from the scientific research assistance of postdoctoral researchers and the team, which is not only the strength of team leaders, but also the result of the joint efforts of team members, large-scale commercial promotion will benefit more patients, and obtain better economic benefits from them, making due contributions to economic and social development. After the postdoctoral researchers leave the station after the expiration of their term, they are actively recommended to continue to carry out major and key technology research in the core positions of scientific research in the subsidiaries under the jurisdiction of the group, and the postdoctoral team has become a reserve pool of senior talents of the company and a new force for scientific research work, and has also played a role in the introduction of talents in our province and city.